Showing results (151-160 of 165) with videos related to
Sort By:
Pageof 17
Cephalalgia : an International Journal of Headache|April 23, 2025
Effectiveness and tolerability of atogepant in the prevention of migraine: A real life, prospective, multicentric study (the STAR study)Fabrizio Vernieri, Luigi Francesco Iannone, Flavia Lo Castro, et al.The Journal of Headache and Pain|January 4, 2024
The World Health Organization Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders and the headache revolution: from headache burden to a global action plan for headache disordersMatilde Leonardi, Paolo Martelletti, Rami Burstein, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 30, 2021
Neuro-telehealth for fragile patients in a tertiary referral neurological institute during the COVID-19 pandemic in Milan, LombardyDavide Pareyson, Chiara Pantaleoni, Roberto Eleopra, et al.Journal of Neurology|January 17, 2024
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational studyPiero Barbanti, Cinzia Aurilia, Gabriella Egeo, et al.Cephalalgia : an International Journal of Headache|November 4, 2020
I stay at home with headache. A survey to investigate how the lockdown for COVID-19 impacted on headache in Italian childrenLaura Papetti, Pierfrancesco Alaimo Di Loro, Samuela Tarantino, et al.International Journal of Environmental Research and Public Health|September 9, 2022
Excellent Response to OnabotulinumtoxinA: Different Definitions, Different PredictorsRaffaele Ornello, Carlo Baraldi, Fayyaz Ahmed, et al.Pain and Therapy|March 29, 2021
Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter StudyRaffaele Ornello, Fayyaz Ahmed, Andrea Negro, et al.The Journal of Headache and Pain|October 26, 2023
Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030Paolo Martelletti, Matilde Leonardi, Messoud Ashina, et al.Pain and Therapy|September 26, 2021
Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 PatientsRaffaele Ornello, Fayyaz Ahmed, Andrea Negro, et al.International Journal of Environmental Research and Public Health|January 20, 2021
The Impact of the SARS-CoV-2 Outbreak on the Psychological Flexibility and Behaviour of Cancelling Medical Appointments of Italian Patients with Pre-Existing Medical Condition: The "ImpACT-COVID-19 for Patients" Multi-Centre Observational StudyGiuseppe Deledda, Niccolò Riccardi, Stefania Gori, et al.Pageof 17